ArticleFrontiers in surgery2026
Case Report: Intramedullary solitary fibrous tumor at the C7-T1 level diagnosed by STAT6 and treated with maximal safe resection.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intramedullary solitary fibrous tumor is an exceptionally rare spindle-cell neoplasm of the central nervous system and is rarely diagnosed before surgery because the clinical presentation and imaging findings are non-specific. We report a man in his early 60s with more than 7 years of progressive bilateral lower-extremity numbness that worsened during the month before admission without an identifiable precipitating event. Magnetic resonance imaging demonstrated an enhancing intramedullary lesion at the C7-T1 level. The patient underwent microscopic tumor resection through a posterior C7-T2 laminectomy under intraoperative ultrasound guidance and multimodal intraoperative neurophysiological monitoring, including somatosensory evoked potentials, transcranial motor evoked potentials, D-wave monitoring, and free-running electromyography. Gross total resection was achieved without new neurological deficit. Histology showed spindle cells in fascicular and storiform arrangements with branching staghorn-like vessels. Immunohistochemistry demonstrated nuclear STAT6 positivity with co-expression of CD34, CD99, and Bcl-2. Mitotic activity was low, with only 2-3 mitoses per 10 high-power fields, and no definite tumor necrosis was identified, supporting the diagnosis of a CNS WHO grade 1 solitary fibrous tumor. Sensory symptoms improved after surgery, and no recurrence was detected on magnetic resonance imaging at 18-month follow-up. This short-term outcome is encouraging, but long-term radiological surveillance remains necessary.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.